SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (B.1.1.529) Omicron variant originated from South Africa in the middle of November 2021. SARS-CoV-2 is also called coronavirus disease 2019 (COVID-19) since SARS-CoV-2 is the causative agent of COVID-19. Several studies already suggested that the SARS-CoV-2 Omicron variant would be the fastest transmissible variant compared to the previous 10 SARS-CoV-2 variants of concern, interest, and alert. Few clinical studies reported the high transmissibility of the Omicron variant but there is insufficient time to perform actual experiments to prove it, since the spread is so fast. We analyzed the SARS-CoV-2 Omicron variant, which revealed a very high rate of mutation at amino acid residues that interact with angiostatin-converting enzyme 2. The mutation rate of COVID-19 is faster than what we prepared vaccine program, antibody therapy, lockdown, and quarantine against COVID-19 so far. Thus, it is necessary to find better strategies to overcome the current crisis of COVID-19 pandemic.
Abstract
Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (B.1.1.529) Omicron variant originated from South Africa in the middle of November 2021. SARS-CoV-2 is also called coronavirus disease 2019 (COVID-19) since SARS-CoV-2 is the causative agent of COVID-19. Several studies already suggested that the SARS-CoV-2 Omicron variant would be the fastest transmissible variant compared to the previous 10 SARS-CoV-2 variants of concern, interest, and alert. Few clinical studies reported the high transmissibility of the Omicron variant but there is insufficient time to perform actual experiments to prove it, since the spread is so fast. We analyzed the SARS-CoV-2 Omicron variant, which revealed a very high rate of mutation at amino acid residues that interact with angiostatin-converting enzyme 2. The mutation rate of COVID-19 is faster than what we prepared vaccine program, antibody therapy, lockdown, and quarantine against COVID-19 so far. Thus, it is necessary to find better strategies to overcome the current crisis of COVID-19 pandemic.
참고문헌 (25)
- Brown CM, "Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings-Barnstable County, Massachusetts, July 2021", MMWR Morb Mortal Wkly Rep, 70, pp.1059~1062 (2021)
- Dagpunar J, "Interim estimates of increased transmissibility, growth rate, and reproduction number of the COVID-19 B.1.617.2 variant of concern in the United Kingdom", MedRxiv. doi: 10.1101, 2021 (2021)
- Liu Y, "The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus", J Travel Med, 28, pp.taab124~ (2021)
- Shi Q, "Rapid global spread of the SARS-CoV-2 delta(B. 1. 617. 2)variant : spatiotemporal variation and public health impact", Zoonoses, 1, pp.1~6 (2021)
- Lopez Bernal J, "Effectiveness of COVID-19 vaccines against the B. 1. 617. 2(Delta)variant", N Engl J Med, 385, pp.585~594 (2021)
- Sheikh A, "SARS-CoV-2 Delta VOC in Scotland : demographics, risk of hospital admission, and vaccine effectiveness", Lancet, 397, pp.2461~2462 (2021)
- Li W, "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus", Nature, 426, pp.450~454 (2003)
- Chen Y, "Structure analysis of the receptor binding of 2019-nCoV", Biochem Biophys Res Commun, 525, pp.135~140 (2020)
- Lan J, "Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor", Nature, 581, pp.215~220 (2020)
- Shang J, "Structural basis of receptor recognition by SARS-CoV-2", Nature, 581, pp.221~224 (2020)
- Song W, "Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2", PLoS Pathog, 14, pp.e1007236~ (2018)
- Wrapp D, "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation", Science, 367, pp.1260~1263 (2020)
- Yan R, "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2", Science, 367, pp.1444~1448 (2020)
- Yuan M, "A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV", Science, 368, pp.630~633 (2020)
- Yuan Y, "Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains", Nat Commun, 8, pp.15092~ (2017)
- Sinae Kim, "The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene", Immune Network, 20(5), pp.1~11 (2020), 대한면역학회[DOI]
- Li F, "Structure of SARS coronavirus spike receptor-binding domain complexed with receptor", Science, 309, pp.1864~1868 (2005)
- Wang Q, "Structural and functional basis of SARS-CoV-2 entry by using human ACE2", Cell, 181, pp.894~904.e9 (2020)
- 전현정, "SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene", Immune Network, 21(5), pp.1~14 (2021), 대한면역학회[DOI]
- Torjesen I, "Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear", BMJ, 375, pp.n2943~ (2021)
- Zhang L, "The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron", Emerg Microbes Infect, 10, pp.1~11 (2021)
- Barrett CT, "Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion", J Biol Chem, 297, pp.100902~ (2021)
- Belouzard S, "Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites", Proc Natl Acad Sci U S A, 106, pp.5871~5876 (2009)
- Simmons G, "Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry", Proc Natl Acad Sci U S A, 102, pp.11876~11881 (2005)
- Simmons G, "Proteolytic activation of the SARS-coronavirus spike protein : cutting enzymes at the cutting edge of antiviral research", Antiviral Res, 100, pp.605~614 (2013)